Haemonetics Inc. (NYSE: HAE) reported Thursday it completed the $60 million tender offer for Global Med Technologies Inc. (NASDAQ: GLOB), according to Associated Press.
Last month, the company said that it would buy the health information technology company for $1.22 per share, and its preferred stock at about $1,694 each.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Haemonetics has tendered 100 percent of the Global Med's preferred stock and 82 percent of outstanding common stock.
The company will provide a subsequent offering period which will expire on March 31, unless extended. It will complete the buyout after the subsequent offering period expires.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
